REG - Symphony Environment - Trading and business update

Symphony Environmental TechnologiesAnnouncement

17/12/2021 14:10

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211217:nRSQ0839Wa&default-theme=true

RNS Number : 0839W  Symphony Environmental Tech. PLC  17 December 2021

The information contained within this announcement is deemed by the Company to
constitute inside information stipulated under the Market Abuse Regulation
(EU) No. 596/2014 as it forms part of UK domestic law by virtue of
the European Union (Withdrawal) Act 2018.  Upon the publication of this
announcement via the Regulatory Information Service, this inside information
is now considered to be in the public domain.

 

17 December 2021

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

("Symphony", the "Company" or the "Group")

 

Trading and Business Update

Improved anti-viral kill rate of d2p gloves

 

Symphony Environmental Technologies Plc (AIM:SYM) global specialists in
technologies that make plastic and rubber products "smarter, safer and
sustainable", is pleased to announce a trading and business update.

Trading update

Group revenue (draft and unaudited) for the financial year ending 31 December
2021 ("FY 2021") is currently expected to be approximately £9.8 million (FY
2020: £9.8 million) resulting in an operating loss of approximately £800,000
(FY 2020: £390,000 and H1 2021: £600,000). As always, this is subject to
completion of final shipment consignments for revenue recognition purposes at
the year end.

Group revenue for FY 2021 by product type is expected to show a 5%
year-on-year increase of d2w masterbatch and a 29% year-on-year increase of
d2p masterbatch. However, finished good sales, particularly of PPE/gloves
reduced year-on-year. Separately, a total of £1.8 million d2p masterbatch and
PPE/glove pipeline revenues, originally expected to be recognised in FY 2021
has been delayed into FY 2022 - further explanation is provided in the
"Business development updates" section below.

Revenue in the final quarter of FY 2021 was comparatively much stronger than
earlier in the year and is expected to total approximately £2.8 million and
be operating break even. On an annualised basis, the Group would be generating
revenue of at least £11.2 million.

Business development updates

The Group continues its investment programmes across several areas each aimed
to stimulate new sales and markets in the short and medium term including
gaining key regulatory and product approvals. The new business pipeline of d2p
technologies and PPE/gloves currently totals over 100 projects for which
management estimate if successfully commercialised would generate in excess of
$40 million of recurring annual revenues.

We are particularly excited by our new d2p glove product which has a proven
coronavirus (see note 1 below) kill rate of 99.99% within just 10 minutes.
This is a massive improvement on our previously reported result which showed a
99.84% kill rate within 24 hours. We are not currently aware of any competitor
gloves offering this combination of speed and protection. Further details are
provided below, but Symphony expect regulatory approvals to market and sell in
the EU and the US to be obtained in Q2 2022. Given the continual mutations of
Covid-19, Symphony is and will continue to seek to launch this new product to
the market as soon as practicable.

It should also be noted that from the sales pipeline, conversion of circa
£1.0 million of revenue from d2p technology projects was anticipated to be
completed before the year end, but due to unforeseen delays beyond the
Company's control have moved into the new trading year. This part of the sales
pipeline covers bread packaging, water pipes and other types of antimicrobial
products. A further £800,000 of PPE/gloves revenues was also expected to be
completed before the end of the financial year but negotiations are taking
longer to complete than anticipated due to the complexity of the technical
requirements.

Listed below are some of the more notable revenue opportunities within the d2p
and PPE/gloves sales pipeline:

-     d2p USA FDA & Canadian approved bread-packaging technology

 

Following successful initial trials during the year, small commercial product
sales have commenced in Latin America with a large bakery for use in one type
of bread packaging. Testing on other types of bread products is continuing
with a progressive programme to expand the evaluation process and eventual use
of d2p in a wide geographical area.

The results from these small-scale commercial trials are expected to be
positive based on data collected to date. Symphony are working closely with
relevant key decision makers of the bread producers as to the benefits to
their business attributable to d2p.

Separately, bread packaging products made with d2p have now been produced to
specific customer specifications for evaluation in Canada, USA, Middle East,
Pakistan, and South Africa. These markets have shown strong interest in using
our d2p technology if the local trials confirm the expected results. The sales
volumes indicated would be potentially large which would then translate into
meaningful Group revenues if the trials and subsequent commercial discussions
proceed as hoped.

 

-     Nitrile disposable gloves made with d2p technology

As noted above, nitrile gloves made with d2p have completed pre-production
trials and also have been successfully tested against ISO Standards for
anti-viral and anti-bacterial performance with kill rates of at least 99.99%
with a recent result showing a coronavirus kill rate of 99.99% within 10
minutes.

Regulatory applications will be made imminently, and if approved, Symphony
currently anticipate will translate to the Group being able to market and sell
in the EU and the US in Q2 2022. Based on current and ongoing communications
with several key customers and distributors, the Board are confident that upon
regulatory approval being received, the Group will be able to generate
immediate and material revenues from the sale of d2p enhanced nitrile gloves
and d2p additives for glove production into these significant geographies.

 

-     Meditech China

In August 2021, Symphony entered into four agreements with Meditech to expand
sales in the Far East and globally. Symphony are pleased with progress to date
and alongside Meditech, Symphony has commenced upgrading current EU CE
certification and US FDA registration. This process is expected to complete in
early Q2 2022.

 

-     Gloves - other

Further to the work being carried out with Meditech, negotiations are taking
place in the USA (for use in medical facilities such as hospitals and clinics)
and Europe (for large retail distributors in Spain and Italy) for d2p gloves
and other finished products. The volumes being discussed would be material to
Symphony.

 

d2w Masterbatch

Volumes of d2w masterbatch increased across Latin America, the Middle East,
and some parts of Asia during FY 2021. We are seeing a positive impact from
the advisory and advocacy work being carried out for our d2w technology in
these markets as well as increasing enforcement of favourable legislation by
the relevant authorities.

India - Symphony Environmental (India) Pvt Ltd

As announced on 23 October 2021, Symphony formed a joint venture ("JV") with
Indorama. Agreement has also been reached for manufacturing and
product-development with an Indian manufacturing group, Bihani. This JV
removes one of the biggest obstacles that previously precluded Symphony from
succeeding in the Indian market as the punitive duties and other import costs
made our products uncompetitive. Based upon work and progress achieved to
date, Symphony are optimistic that this new relationship and structure will
provide significant revenue opportunities for both d2w and d2p products during
FY 2022 and beyond.

 

Note 1: Coronavirus strain MHV-3 genus Betacoronavirus (same family and genus
as SARS-CoV-1, SARS- CoV-2/COVID19 and MERS)

 

 

 Enquiries

 Symphony Environmental Technologies Plc
 Michael Laurier, CEO                                                  Tel: +44 (0) 20 8207 5900
 Ian Bristow, CFO
 www.symphonyenvironmental.com (http://www.symphonyenvironmental.com)

 Zeus Capital Limited (Nominated Adviser and Joint Broker)
 David Foreman / Kieran Russell / Guy Brinkley (Corporate Finance)     Tel: +44 (0) 161 831 1512
 Dominic King / Victoria Ayton (Sales)                                 Tel: +44 (0) 203 829 5000

 Hybridan LLP (Joint Broker)

 Claire Louise Noyce                                                   Tel: +44 (0) 203 764 2341

The person responsible for arranging the release of this information is
Michael Laurier, CEO of the Company.

 

NOTES TO EDITORS:

About Symphony Environmental Technologies plc

www.symphonyenvironmental.com (http://www.symphonyenvironmental.com)

Symphony has developed a range of additives, concentrates and master-batches
marketed under its d2p® ("designed to protect") trademark, which can be
incorporated in a wide variety of plastic and non-plastic products so as to
provide protection against many different types of microbes, and insects and
rodents, and against fire. d2p products also include odour, moisture and
ethylene adsorbers as well as other types of food-preserving technologies.
Symphony has launched d2p anti-microbial household gloves and toothbrushes and
is developing a range of other d2p finished products for retail sale.  See
www.d2p.net

Symphony has developed and continues to develop and market, a biodegradable
plastic technology which helps tackle the problem of microplastics by turning
ordinary plastic at the end of its service-life into biodegradable materials.
It is then no longer a plastic and can be bioassimilated in the open
environment in a similar way to a leaf. The technology is branded d2w® and
appears as a droplet logo on many thousands of tonnes of plastic packaging and
other plastic products around the world. In some countries, including Saudi
Arabia, Jordan, Bahrain and the UAE oxo-biodegradable plastic is mandatory.
See www.d2w.net

The Group has complemented its d2w biodegradable product range with d2c
"compostable resins and products" that have been tested to US and EU
composting standards.

Symphony has also developed the d2Detector®, a portable device which analyses
plastics and detects counterfeit products.  This is useful to government
officials tasked with enforcing legislation, and Symphony's d2t tagging and
tracer technology is available for further security.

Symphony has a diverse and growing customer-base and has established itself as
an international business with 74 distributors around the world. Products made
with Symphony's plastic technologies are now available in nearly 100 countries
and in many different product applications. Symphony itself is accredited to
ISO9001 and ISO14001.

Symphony is a member of The OPA (www.biodeg.org) and actively participates in
the Committee work of the British Standards Institute (BSI), the American
Standards Organisation (ASTM), the European Standards Organisation (CEN), and
the International Standards Organisation (ISO).

Further information on the Group can be found at www.symphonyenvironmental.com
and twitter @SymphonyEnv   See also Symphony on Instagram. A Symphony App is
available for downloading to smartphones.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTGZMMZDNNGMZM